Sign in
4

Changes in Ownership

TransMedics Group, Inc. Filed Acc 0000950170-23-033565

Chief Commercial Officer sold 5,000 shares at $95.37 ($476,850)

  • Chief Commercial Officer acquired 5,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Khayal Tamer I · Chief Commercial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-07-18 Exercise or conversion : show line 1 in the form +3,539 $16.14 $57,119 17,914 D
2023-07-18 Exercise or conversion : show line 2 in the form +1,461 $38.46 $56,190 19,375 D
2023-07-18 Sale : show line 3 in the form −5,000 $95.37 $476,850 14,375 D
Open-market sales · 5,000 sh · avg $95.37 · $476,850

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-07-18 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −3,539 17,710 D
2023-07-18 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −1,461 68,539 D
Loading xslF345X05/ownership.xml…